Women's Isoflavone Soy Health (WISH) Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

April 12, 2004

Primary Completion Date

March 19, 2009

Study Completion Date

March 19, 2009

Conditions
Atherosclerosis
Interventions
DIETARY_SUPPLEMENT

25 gm soy protein supplement

25 gm soy protein supplementation administered in equally divided dosage twice daily (12.5 gm)

OTHER

Placebo

Milk protein administered twice daily

Trial Locations (1)

90033

Atherosclerosis Research Unit, University of Southern California, Los Angeles

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

Office of Dietary Supplements (ODS)

NIH

collaborator

Office of Research on Women's Health (ORWH)

NIH

collaborator

Solae, LLC

INDUSTRY

lead

University of Southern California

OTHER

NCT00118846 - Women's Isoflavone Soy Health (WISH) Trial | Biotech Hunter | Biotech Hunter